Apollo Endosurgery Inc Beta
Cos'è Beta di Apollo Endosurgery Inc?
Beta di Apollo Endosurgery Inc è 0.00
Qual è la definizione di Beta?
BETA indica se una azione è più o meno volatile rispetto al mercato nel suo complesso. Un beta inferiore a 1 indica che la azione è meno volatile rispetto al mercato, mentre un beta più di 1 indica che la azione è più volatile. La volatilità è misurata come la fluttuazione del prezzo attorno alla media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta di aziende nel Health Care settore su NASDAQ rispetto a Apollo Endosurgery Inc
Cosa fa Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Aziende con beta simili a Apollo Endosurgery Inc
- Vision Marine Technologies ha Beta di 0.00
- Ely Gold Royalties ha Beta di 0.00
- Glacier Lake Resources ha Beta di 0.00
- Magnum Mining and Exploration ha Beta di 0.00
- Africa Opportunity Fund ha Beta di 0.00
- Fulcrum Utility Services ha Beta di 0.00
- Apollo Endosurgery Inc ha Beta di 0.00
- Gullewa ha Beta di 0.00
- S.A.L. Steel ha Beta di 0.00
- Andina Acquisition III ha Beta di 0.00
- Andina Acquisition III ha Beta di 0.00
- Brilliant Acquisition ha Beta di 0.00
- Indokem ha Beta di 0.00